About HAE

Learn more about hereditary angioedema (HAE) hereditary angioedema
FIRAZYR is indicated for the treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older.
Share / Send / Save

Here, you will find a basic overview of HAE, a rare, debilitating and potentially life-threatening disease that can cause swelling in almost any anatomical site.1,2 Learn about the epidemiology of HAE, the role of genetics and how bradykinin is thought to play a role in its characteristic symptoms.

HAE Overview

Get basic facts about the incidence, age of onset and frequency of HAE attacks, as well as its genetic basis.

Learn about HAE »

Role of Bradykinin

Bradykinin is thought to be responsible for the characteristic HAE symptoms of localized swelling and pain.3

Review the role of bradykinin in HAE »